| abstract |
Methods for treating proliferative diseases, especially breast cancers, comprising administering (1) a therapeutically effective amount of a liposomal anthracycline composition in association with (2) a therapeutically effective amount of an antibody directed against the extracellular domain of a growth factor receptor and optionally in association with (3) a therapeutically effective amount of an additional antineoplastic agent, are disclosed. |